DISCLOSURE NOTICE: The information in this press release, the comments
of Schering-Plough officers during the earnings teleconference/webcast on
Oct. 22, 2007, beginning at 8 a.m. (EDT), and other written reports and
oral statements made from time to time by the company may contain
"forward-looking statements" within the meaning of the Private Securities
Litigation Reform Act of 1995. Forward-looking statements do not relate
strictly to historical or current facts and are based on current
expectations or forecasts of future events. You can identify these
forward-looking statements by their use of words such as "anticipate,"
"believe," "could," "estimate," "expect," "forecast," "project," "intend,"
"plan," "potential," "will," and other similar words and terms. In
particular, forward-looking statements include statements relating to the
company's plans; its strategies; its progress under the Action Agenda and
anticipated timing regarding future performance of the Action Agenda;
business prospects; anticipated growth; timing and conditions of regulatory
approvals and expected synergies related to the Organon BioSciences
acquisition; prospective products or product approvals; trends in
performance; anticipated timing of clinical trials and its impact on R&D
spending; anticipated exclusivity periods; actions to enhance clinical,
|SOURCE Schering-Plough Corporation|
Copyright©2007 PR Newswire.
All rights reserved